{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:44:37Z","timestamp":1789404277588,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jsbmb.2009.03.008","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T04:40:29Z","timestamp":1238733629000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites"],"prefix":"10.1016","volume":"116","author":[{"given":"Aur\u00e9lie","family":"Escande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Servant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanja","family":"Rabenoelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Auzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenius","family":"Kloosterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cavaill\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maudelonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2009.03.008_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Dose\u2013response analysis of effects of tibolone on climacteric symptoms","volume":"109","author":"Landgren","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women: systematic review of randomized trials","volume":"87","author":"Modelska","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-5122(83)90004-X","article-title":"Efficacy and safety of Org OD 14 in the treatment of climacteric complaints","volume":"5","author":"Trevoux","year":"1983","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib4","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jcem.86.10.7937","article-title":"Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 19","key":"10.1016\/j.jsbmb.2009.03.008_bib5","first-page":"1","article-title":"Livial: a review of clinical studies","volume":"106","author":"Moore","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00002018-200528030-00005","article-title":"Tibolone and endometrial cancer. A cohort and nested case\u2013control study in the UK","volume":"28","author":"de Vries","year":"2005","journal-title":"Drug Safety"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.fertnstert.2006.12.052","article-title":"Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women","volume":"88","author":"Archer","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1592\/phco.22.1.6.33495","article-title":"Dose proportionality of three different doses of tibolone","volume":"22","author":"Timmer","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0039-128X(02)00112-5","article-title":"Receptor profiling and endocrine interactions of tibolone","volume":"68","author":"De Gooyer","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00044-9","article-title":"Tibolone: a steroid with a tissue-specific mode of action","volume":"76","author":"Kloosterboer","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0960-0760(97)00160-X","article-title":"Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens","volume":"64","author":"Dijkema","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0048-9697(99)00178-3","article-title":"Reporter cell lines to study the estrogenic effects of xenoestrogens","volume":"233","author":"Balaguer","year":"1999","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bcp.2006.02.002","article-title":"Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta","volume":"71","author":"Escande","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(99)00251-8","article-title":"A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects","volume":"160","author":"Terouanne","year":"2000","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.taap.2006.04.005","article-title":"Steroid receptor profiling of vinclozolin and its primary metabolites","volume":"216","author":"Molina-Molina","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0039-128X(02)00021-1","article-title":"Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite","volume":"67","author":"Bodine","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00042192-200207000-00011","article-title":"Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tibolone","volume":"9","author":"Wiegratz","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib19","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.95.11.5998","article-title":"Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains","volume":"95","author":"Tanenbaum","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1124\/mol.104.004515","article-title":"Tibolone is metabolized by the 3alpha\/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid","volume":"66","author":"Steckelbroeck","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib21","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/endo.142.9.8401","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1933719106298684","article-title":"Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate","volume":"14","author":"Verheul","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(96)01069-9","article-title":"Effect on sexual life\u2014a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen","volume":"26","author":"Nathorst-Boos","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2009.03.008_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(00)01768-4","article-title":"Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy","volume":"75","author":"D\u00f6ren","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib25","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib26","doi-asserted-by":"crossref","first-page":"22748","DOI":"10.1074\/jbc.M212711200","article-title":"The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism","volume":"278","author":"Kauppi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1124\/mol.62.6.1306","article-title":"11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells","volume":"62","author":"Rafestin-Oblin","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/mol.106.031112","article-title":"The synthetic androgen methyltrienolone (R1881) acts as a potent antagonist of the mineralocorticoid receptor","volume":"71","author":"Takeda","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2009.03.008_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1460789","article-title":"Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor","volume":"146","author":"Quinkler","year":"2002","journal-title":"Eur. J. Endocrinol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:58:35Z","timestamp":1760734715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076009001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0960076009001125"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.03.008","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}